MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biomaterials (Orthopedic: Synthetic Bone, Cartilage & Skin Substitutes)
MiMedx Group, Inc. (NASDAQ:MDXG)
Organization & Developments: MiMedx
Parents
MiMedx Group, Inc. (NASDAQ:MDXG)
Children
*Develops biomaterial-based products for use in the musculoskeletal specialties.
*HydroFix Vaso Shield and HydroFix Spine Shield products
2016: MiMedx Group, Inc.: A Fundamentally Solid Biomaterials Company Poised For Growth - MiMedx Group Inc. (NASDAQ:MDXG)
2018: Amid buzz around a short seller’s FBI visit, MiMedx stock craters following internal investigation – Endpoints News
2018: MiMedx: More Explosive Price Action Might Soon Be Here - MiMedx Group Inc. (NASDAQ:MDXG)
2018: MiMedx’s leadership begins to unravel following internal and external investigations
2018: The Cloud of Uncertainty Thickens Over MiMedx As Auditor Quits
2018: The Market Is Rightfully Nervous Over MiMedx's Latest Bad News - MiMedx Group Inc. (NASDAQ:MDXG)
2019: 10 Reasons To Buy MiMedx Stock Today_seekingalpha.com
2019: MiMedx - All In On This Home Run Stock_seekingalpha.com
2019: MiMedx: Why I'm Buying The Breakout_seekingalpha.com
2019: SEC charges ex-MiMedx execs with defrauding investors
2020: Former MiMedx CEO and COO are convicted on fraud, conspiracy charges
2020: MiMedx: Amniotic Hypotheses Create Decent Fundamental Momentum
2020: MiMedx: This Is What Institutional Investment Looks Like
2021: MiMedx: Aggressively Adding Shares Here
2021: Placental Allografts for Diabetic Foot Ulcers: Interview with Tim Wright, CEO of MiMedx
2022: MiMedx Group, Inc. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2023: Unraveling MiMedx's Surgical Precision In Growth (NASDAQ:MDXG)
2024: MiMedx Group: Restructuring Changes Are Paying Off_ seekingalpha.com
Jumps
*Key People: MiMedx
Finance & Acquisitions: MiMedx